Reported Tuberculosis in the United States, 2017

Return to Main Menu

Table 48. Tuberculosis Cases and Percentages, by Directly Observed Therapy (DOT): Reporting Areas, 20151

Table 48. Tuberculosis Cases and Percentages, by Directly Observed Therapy (DOT): Reporting Areas, 2015
Reporting Area Total Cases Cases with Initial Drug Regimen Prescribed2 Cases with Information on Directly Observed Therapy Percentage of Cases by Directly Observed Therapy3
No. (%) DOT Only Both DOT and Self-Administered
United States 9,547 9,288 9,174 (98.8) (65.1) (28.5)
Alabama 119 116 115 (99.1) (59.1) (40.9)
Alaska 68 67 67 (100.0) (98.5) (1.5)
Arizona 198 194 194 (100.0) (89.2) (8.8)
Arkansas 90 88 88 (100.0) (36.4) (62.5)
California 2,131 2,073 2,033 (98.1) (53.4) (38.5)
Colorado 73 72 72 (100.0) (69.4) (23.6)
Connecticut 70 70 70 (100.0) (20.0) (61.4)
Delaware 22 21 20 (95.2) (45.0) (55.0)
District of Columbia 33 30 30 (100.0) (86.7) (0.0)
Florida 602 583 576 (98.8) (20.8) (78.6)
Georgia 320 314 313 (99.7) (90.1) (7.3)
Hawaii 127 126 126 (100.0) (92.1) (2.4)
Idaho 11 11 10 (90.9) (50.0) (20.0)
Illinois 343 335 333 (99.4) (49.8) (38.1)
Indiana 116 114 114 (100.0) (89.5) (9.6)
Iowa 38 38 38 (100.0) (55.3) (39.5)
Kansas 36 35 34 (97.1) (94.1) (5.9)
Kentucky 67 67 67 (100.0) (94.0) (6.0)
Louisiana 119 115 91 (79.1) (56.0) (29.7)
Maine 18 17 17 (100.0) (47.1) (41.2)
Maryland 176 171 171 (100.0) (78.9) (21.1)
Massachusetts 192 187 186 (99.5) (72.6) (18.3)
Michigan 131 130 130 (100.0) (62.3) (37.7)
Minnesota 150 146 146 (100.0) (42.5) (56.8)
Mississippi 73 70 69 (98.6) (66.7) (33.3)
Missouri 92 90 89 (98.9) (21.3) (76.4)
Montana 9 8 8 (100.0) (100.0) (0.0)
Nebraska 33 32 28 (87.5) (10.7) (75.0)
Nevada 85 82 81 (98.8) (76.5) (19.8)
New Hampshire 13 12 12 (100.0) (41.7) (58.3)
New Jersey 326 314 303 (96.5) (51.5) (29.4)
New Mexico 47 41 41 (100.0) (90.2) (9.8)
New York State4 188 184 183 (99.5) (22.4) (73.8)
New York City 575 564 562 (99.6) (59.6) (13.9)
North Carolina 199 192 192 (100.0) (96.4) (3.1)
North Dakota 9 8 8 (100.0) (25.0) (75.0)
Ohio 143 139 139 (100.0) (71.9) (15.8)
Oklahoma 67 62 62 (100.0) (6.5) (93.5)
Oregon 76 75 75 (100.0) (89.3) (6.7)
Pennsylvania 200 196 196 (100.0) (69.4) (24.5)
Rhode Island 30 28 28 (100.0) (10.7) (89.3)
South Carolina 104 100 100 (100.0) (80.0) (18.0)
South Dakota 17 15 15 (100.0) (60.0) (26.7)
Tennessee 131 127 127 (100.0) (92.1) (7.9)
Texas 1,334 1,303 1,301 (99.8) (94.7) (4.9)
Utah 37 37 37 (100.0) (100.0) (0.0)
Vermont 7 7 7 (100.0) (57.1) (28.6)
Virginia 212 208 208 (100.0) (93.3) (6.3)
Washington 207 196 185 (94.4) (64.9) (18.4)
West Virginia 10 8 7 (87.5) (100.0) (0.0)
Wisconsin 69 66 66 (100.0) (87.9) (12.1)
Wyoming 4 4 4 (100.0) (25.0) (50.0)
American Samoa5 4 4
Fed. States of Micronesia5 103 102 102 (100.0) (92.2) (7.8)
Guam5 76 73 47 (64.4) (91.5) (8.5)
Marshall Islands5 136 133 131 (98.5) (87.8) (11.5)
N. Mariana Islands5 27 27 26 (96.3) (80.8) (19.2)
Puerto Rico5 52 48 47 (97.9) (72.3) (0.0)
Republic of Palau5 14 14 14 (100.0) (50.0) (50.0)
U.S. Virgin Islands5

1 Most recent year for which data are available.
2 Includes persons alive at diagnosis with an initial drug regimen of one or more drugs prescribed.
3 Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia).
4 Excludes New York City.
5 Not included in U.S. totals.
Note: Ellipses (…) indicate that the percentage cannot be calculated, and the denominator is 0.

Page last reviewed: October 22, 2018